Literature DB >> 15814019

Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.

Sven Törnberg1, Mary Codd, Vitor Rodrigues, Nereo Segnan, Antonio Ponti.   

Abstract

OBJECTIVES: The purpose of the present study was to estimate the interval cancer (IC) rates in four population-based mammography screening programmes in four countries with different health-care environments, different access to cancer registry data, and different age groups of women invited.
SETTING: The screening programmes in Coimbra (Portugal), Dublin (Ireland), Stockholm (Sweden), and Turin (Italy) participated in the study.
METHODS: All cancer cases were searched for in cancer registries. IC rates and other outcome measures from the screening programmes were estimated and compared between the centres. Poisson regression model was used to estimate the proportional incidence based on IC rate in relation to expected total breast cancer incidence rate in the absence of screening.
RESULTS: There was a more than tenfold difference in the number of invited women at the first round between the involved centres. The IC rates varied between 4.3 and 23.8 per 10,000 women screened. The levels of IC rates in relation to the estimated background incidence varied from 0.35 up to 0.46 depending on age groups involved in the programme, but did not differ significantly between three of the four involved centres.
CONCLUSIONS: IC rates were quite similar between three of the four centres despite the differences in target population, invited ages, length of building-up of the programmes and different health-care organizations. Different access to complete cancer registry data is likely to explain the lower IC rates in the fourth centre.

Entities:  

Mesh:

Year:  2005        PMID: 15814019     DOI: 10.1258/0969141053279077

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  10 in total

1.  Comparing sensitivity and specificity of screening mammography in the United States and Denmark.

Authors:  Katja Kemp Jacobsen; Ellen S O'Meara; Dustin Key; Diana S M Buist; Karla Kerlikowske; Ilse Vejborg; Brian L Sprague; Elsebeth Lynge; My von Euler-Chelpin
Journal:  Int J Cancer       Date:  2015-06-01       Impact factor: 7.396

Review 2.  Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Authors:  Swann Arp Adams; James R Hebert; Susan Bolick-Aldrich; Virginie G Daguise; Catishia M Mosley; Mary V Modayil; Sondra H Berger; Jane Teas; Michael Mitas; Joan E Cunningham; Susan E Steck; James Burch; William M Butler; Marie-Josephe D Horner; Heather M Brandt
Journal:  J S C Med Assoc       Date:  2006-08

3.  Comparing screening mammography for early breast cancer detection in Vermont and Norway.

Authors:  Solveig Hofvind; Pamela M Vacek; Joan Skelly; Donald L Weaver; Berta M Geller
Journal:  J Natl Cancer Inst       Date:  2008-07-29       Impact factor: 13.506

4.  Mammographic features and histopathological findings of interval breast cancers.

Authors:  S Hofvind; B Geller; P Skaane
Journal:  Acta Radiol       Date:  2008-11       Impact factor: 1.990

5.  Breast Cancer Screening in Asian Women with Dense Breast by Mammography: A Cross-Sectional Observational Study.

Authors:  Jung Sun Lee; Minkyung Oh
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

6.  Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.

Authors:  Stephen W Duffy; Amanda Dibden; Dimitrios Michalopoulos; Judith Offman; Dharmishta Parmar; Jacquie Jenkins; Beverley Collins; Tony Robson; Suzanne Scorfield; Kathryn Green; Clare Hall; Xiao-Hui Liao; Michael Ryan; Fiona Johnson; Guy Stevens; Olive Kearins; Sarah Sellars; Julietta Patnick
Journal:  Lancet Oncol       Date:  2015-12-05       Impact factor: 41.316

7.  Mortality reductions due to mammography screening: Contemporary population-based data.

Authors:  James A Hanley; Ailish Hannigan; Katie M O'Brien
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

8.  Mammographic density and survival in interval breast cancers.

Authors:  Louise Eriksson; Kamila Czene; Lena U Rosenberg; Sven Törnberg; Keith Humphreys; Per Hall
Journal:  Breast Cancer Res       Date:  2013-06-20       Impact factor: 6.466

9.  Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response.

Authors:  Gina Marrão; Mohammed Habib; Artur Paiva; Dominique Bicout; Catherine Fallecker; Sofia Franco; Samira Fafi-Kremer; Teresa Simões da Silva; Patrice Morand; Carlos Freire de Oliveira; Emmanuel Drouet
Journal:  BMC Cancer       Date:  2014-09-11       Impact factor: 4.430

10.  Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening.

Authors:  Laura Steponaviciene; Ieva Vincerzevskiene; Ruta Briediene; Vincas Urbonas; Rasa Vanseviciute-Petkeviciene; Giedre Smailyte
Journal:  Cancer Control       Date:  2019 Jan-Dec       Impact factor: 3.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.